Immediate Impact

51 standout
Sub-graph 1 of 25

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
2024 Standout
2 intermediate papers

Works of Sara Hamilton being referenced

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment-Related Adverse Events From the CheckMate 040 Study
2020

Author Peers

Author Last Decade Papers Cites
Sara Hamilton 124 133 111 21 413
Jia Zhu 113 156 9 38 503
Ruoqi Wang 39 200 61 34 490
Anneliene Hechtelt Jonker 222 168 11 25 469
Chung C. Liu 37 177 6 12 474
Sandy Raeburn 126 158 13 21 508
Erik Tambuyzer 134 139 8 12 407
Theo Papakonstantinou 30 123 17 24 397
Yavuz Bayram 200 309 27 22 490
Heather M. Shappell 109 157 22 23 461
Margaret Takeda 10 199 8 16 416

All Works

Loading papers...

Rankless by CCL
2026